Clinical trial
Multicenter Study Comparing the Efficacy and Safety of OROS (Methylphenidate HCl), Ritalin, and Placebo in Children With ADHD
NCT00269802 is registered in ClinicalTrials.gov with Alza Corporation, DE, USA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Study Comparing the Efficacy and Safety of OROS (Methylphenidate HCl), Ritalin, and Placebo in Children With ADHD
- Lead sponsor
- Alza Corporation, DE, USA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- February 28, 1999
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit hyperactivity disorder